Inspiring Health
Transforming Care

Board of Directors

The Ingham Institute’s Board brings together the expertise of medical researchers, health management professionals and local business leaders.

All have extensive personal experience of the diverse and dynamic population of South Western Sydney and are committed to strengthening the capacity and reputation of the Ingham Institute as a world-leading centre of research excellence.


Board of Directors

Terry Goldacre is the Managing Director of Harrington Estates (NSW) Pty Ltd, which since 1993 has been responsible for the development of the leading residential estate Harrington Park. Prior to this, he held executive positions in the civil engineering and land development industries

He is past president of the Urban Development Institute of Australia (NSW Division) and is a founding trustee of the Harrington Park Foundation.

Amanda Larkin is the Chief Executive of South Western Sydney Local Health District. Previously Amanda worked as the General Manager of Camden and Campbelltown Hospitals and the Queen Victoria Memorial Home.

Dr. Larkin has a Bachelor of Social Work, Associate Diploma in Environmental Service and is working towards a Doctorate in Business Administration.

Amanda has over 25 years of experience in health service management working in the areas of community health, corporate services and acute service management in small and large health services.

Amanda currently serves as a Board member of the Ingham Institute of Applied Medical Research and the South Western Sydney Medicare Local.

She has done extensive work with management committees and boards of non-government organisations including neighbourhood centres, day care centres, short term and accommodation facilities for men and women. Her specific areas of focus are leadership, governance, patient quality and safety and health service planning and development.

Professor Annemarie Hennessy AM is the Dean and Foundation Chair of Medicine at Western Sydney University.

She was the Director of the Hypertensive Disorders of Pregnancy (HDP) Unit at the Royal Prince Alfred Women and Babies (RPAWB) from 1998 until October 2006 and continues in an honorary capacity within the unit.

Annemarie has a commitment to medical research in her capacities as Dean of the School of Medicine, WSU.
She is also the group leader of the Vascular Immunology Group at the Heart Research Institute, Director of the NHMRC Baboon Colony, Chair of the NSW University Physician Training Council and Executive Director of the PEARLS Research Group.

Annemarie is a Renal Physician with a research interest in Hypertension and Hypertension in pregnancy, which she has now been working on for 17 years.

“The broad range of research at the Ingham Institute is very exciting. Its particular strength … is the translation of its research into everyday medicine.”

— Professor Hennessy


Arnold Vitocco is a local Macarthur resident and licensed builder. His family’s development company, D. Vitocco Constructions Pty Ltd, has been building and developing in the Liverpool and Macarthur region since the late 1950s. Notable developments by his family company include the Narellan Town Centre and Gregory Hills, a 2,500-lot subdivision and 43 hectares of employment zone.

Arnold is a member of Narellan Chamber of Commerce and is a committee member of the St Gregory’s College, Campbelltown. He was a Board Director of the South Western Sydney Area Health Service 1997-2003 and a committee member of the Health Research Foundation Sydney South West, which successfully helped raise $8 million.

“The Ingham Institute is about medical research and the wellbeing of people. [Medical research requires] forward planning. If you plant a tree today, in 15 years you will have shade. It’s the same with medical research. We must invest in research to reap those long term rewards.”

— Arnold Vitocco


Debbie is a Director and Co-owner of Ingham Property Group which is involved in the development of property assets across New South Wales, Queensland and Western Australia.

Debbie’s passion of thoroughbred horse racing is manifested through being a Director of Ingham Racing & Woppitt Bloodstock. She is also a lucky being part owner of the champion racehorse Winx.

Debbie founded & sits on the board of Pamarma Private Ancillary Fund. A charitable foundation focusing grants to grass root charities.

‘Seeing Dad’s vision for Southwest Sydney blossoming through the amazing work of the researchers & clinicians of the Ingham Institute makes me incredibly proud.”


Jim Marsden OAM is the Senior Partner at Marsdens Law Group. His firm is based primarily at Campbelltown with offices at Liverpool, Camden and the City of Sydney.

Jim has a history in a number of areas of community involvement. His past involvement includes Chairman of West Magpie Rugby League, Wests Tigers, the Chamber of Commerce, and board membership of NSW Rugby League and Odyssey House.

Jim currently Chairs The Macarthur Club and the Macarthur Development Advisory Group based out of Campbelltown.

“Medical research is essential and exciting. I was born and raised in south-west Sydney, and the Ingham Institute gives me the opportunity to participate in the delivery of significant research outcomes in my territory.”

— Jim Marsden


John is a serial entrepreneur, active across diverse sectors including marketing, agriculture, property development, technology, horse breeding and racing.

After a highly successful marketing career at Ingham Enterprises, John continues to build brands as a Director of Upstart Marketing, and Chair of the Ingham Institute Marketing and Fundraising Committee.

As Director and Co-owner of Ingham Property Group, John has a strategic and governance role in the development of property assets across New South Wales, Queensland and Western Australia.

Complimenting Johns wealth of experience, horse breeding and racing is another passion for John, as Director of Ingham Racing, Rockingham Thoroughbreds and James Harron Bloodstock. Previously John held Director roles with the Australian Jockey Club and the Australian Stud Book (2008 – 2012).

A founding investor and Director of farming and livestock SAAS company Agriwebb, brings John’s heritage in food production together with his curiosity for agriculture and technology.

 “The incredible contribution that our research teams are making to the health of our local and national community, and in fact global health issues, makes me feel humble and proud.” John Ingham

Karen is the General Manager of Liverpool Hospital. Karen has experience in leading teams for the planning, building and commissioning of the Fiona Stanley Hospital in Western Australia, as well as experience in implementing service delivery models, achieving activity and financial performance targets, operations management, financial accountability, emergency management and strategic planning and Population Health.

Karen is also an Australian Council of Healthcare Standards (ACHS) Surveyor.

Mark Perich started his career on the family farm, but now concentrates his attention on the helm of the Perich Group’s property business – Greenfields Development Company. Combined with his agricultural and aviation business experience, Mark is steering Greenfield’s to becoming a significant Australian property development leader.
Through Greenfields, Mark now manages major development projects in South-West Sydney including Oran Park Town, WestPort Logistics hub at Western Sydney Airport and with venture partners, developments at Gregory Hills and in South-East Queensland at Covella.
Mark is also directly involved with Perich Group’s retail portfolio including Narellan Town Centre and Oran Park Podium. In addition, Mark has responsibility for the delivery of Oran Park’s town centre, now home to Camden Council. Mark also has experience with bulky goods retail and Employment Land developments.

Professor Martin Gallagher is Head of the Clinical School and Precinct in South Western Sydney for the University of New South Wales, and a Clinical Academic in Renal Medicine at Liverpool Hospital. Prior to taking up his current role, he was a Clinical Academic at Concord Hospital and the University of Sydney. He completed a Harkness Fellowship at Yale University in 2009-10 and his research interests encompass acute kidney injury, clinical trials and renal epidemiology. He’s led a team of clinical renal researchers at the George Institute for Global Health, along with international collaborators.

Martin has also made important policy contributions to healthcare, including leading national evidence implementation projects, leading elements of the Australian Governments National Chronic Disease Strategy and projecting the future burden of kidney disease. He has been Departmental Head at two renal units, held senior committee roles within the Australia and New Zealand Society of Nephrology and led major clinical trials.


Morris Iemma served as Premier of NSW from 2005-2008 and prior to that held the ministerial portfolios of Treasury, Health, Sport and Recreation, Public Works and Services, and Minister Assisting the Premier. During his Parliamentary career he held the seats of Hurstville and Lakemba, in the South District.

Mr Iemma is currently a board member of TAFE NSW and is Chairman of Riverwood Community Centre, Miracle Babies Foundation and NSW Cancer Institute. He has also served on the Boards of Beyond Blue, the SCG Trust and as Chair of the South East Sydney Health District.


Dr Teresa Anderson is the Chief Executive of the Sydney Local Health District,  providing services to more than 600,000 people in Sydney and beyond.

Dr Teresa Anderson has worked in the NSW public health system for more than 30 years and has extensive experience as a clinician, manager and health service leader. She has held positions as the Director, Clinical Operations, Sydney South West Area Health Service, General Manager, Liverpool Hospital and Director of Community and Allied Health Services for the Liverpool Health Service.

She serves on the boards of the Ingham Institute, Centenary Institute, Heart Research Institute, ANZAC Research Institute and Healthshare, and is also the Chair of the Sydney Research Council.

Dr Anderson is focused on supporting collaboration and building partnerships to provide excellent health care. She is widely acknowledged for supporting and mentoring her staff in fostering new ideas to drive efficiencies and best practice.

Tim Bryan is the Chief Executive Officer of the Perich Group and a Chartered Accountant.

He is a Founding Director and Chairman of the Finance Committee, Kids of Macarthur Health Foundation and Chairman of St Gregory’s College Finance Advisory Committee.

Tim has a special interest in research into childhood diseases.

“What excites me most … is the motivation and passion of the researchers who call Ingham Institute home.”

— Tim Bryan


Scientia Professor Vlado Perkovic is the Dean of Medicine and Health at the University of New South Wales in Sydney, Australia, an active clinician and a leading clinical trialist. Prior to commencing his current role in 2019, Professor Perkovic was Executive Director of The George Institute, Australia. He is a part time (0.1 FTE) Staff Specialist in Nephrology at the Royal North Shore Hospital. His research focus is on clinical trials and epidemiology, in particular in preventing the progression of kidney disease and its complications. He has served on the Steering Committees of a large number of international clinical trials including some that have completed- CREDENCE (Chair), TESTING (Chair), CARMELINA (Co-Chair), SONAR and CANVAS- and several that are ongoing- FLOW (Chair), ZEUS (Co-Chair), ASPIRED (Co-Chair), RESOLVE, and TRACK.

He has played a central role in the development of an affordable dialysis system, which was a Eureka Prize finalist in 2017 and won first prize in the World Innovation Summit for Health 2020 Innovation Booster competition.

He has previously been a member of the National Health and Medical Research Council Principal Committee on Research Translation, the Board of the Australian Clinical Trials Alliance. was President of the Association of Australian Medical Research Institutes (AAMRI), and was Chair of the International Society of Nephrology Advancing Clinical Trials (ISN-ACT) group.

He is a Fellow of the Australian Academy of Health and Medical Sciences, has been classified as a Highly Cited Researcher by Clarivate (among the top 0.1% of most cited authors worldwide in 2019 and 2020) and serves on the Editorial Boards of a number of leading specialist and general journals, including the Journal of the American Society of Nephrology, Circulation, and the New England Journal of Medicine.